DiamondRock Hospitality (DRH) Surpasses Q3 FFO and Revenue Estimates
ZACKS· 2025-11-07 07:46
DiamondRock Hospitality (DRH) came out with quarterly funds from operations (FFO) of $0.29 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to FFO of $0.26 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an FFO surprise of +16.00%. A quarter ago, it was expected that this hotel and resort real estate investment trust would post FFO of $0.33 per share when it actually produced FFO of $0.35, delivering a surprise of +6. ...
Drilling Tools International Corp. (DTI) Tops Q3 Earnings and Revenue Estimates
ZACKS· 2025-11-07 07:46
Drilling Tools International Corp. (DTI) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to earnings of $0.14 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +300.00%. A quarter ago, it was expected that this company would post earnings of $0.04 per share when it actually produced a loss of $0.02, delivering a surprise of -150%.Over the last ...
Fidelity National Financial (FNF) Q3 Earnings and Revenues Top Estimates
ZACKS· 2025-11-07 07:46
Fidelity National Financial (FNF) came out with quarterly earnings of $1.63 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.3 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +13.99%. A quarter ago, it was expected that this provider of title insurance and mortgage services would post earnings of $1.4 per share when it actually produced earnings of $1.16, delivering a surprise ...
HireQuest, Inc. (HQI) Surpasses Q3 Earnings and Revenue Estimates
ZACKS· 2025-11-07 07:46
HireQuest, Inc. (HQI) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.2 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +71.43%. A quarter ago, it was expected that this company would post earnings of $0.11 per share when it actually produced earnings of $0.15, delivering a surprise of +36.36%.Over the last four quarters, the company ...
IREN Limited (IREN) Reports Q1 Loss, Beats Revenue Estimates
ZACKS· 2025-11-07 07:46
IREN Limited (IREN) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of $0.14. This compares to a loss of $0.22 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -342.86%. A quarter ago, it was expected that this company would post earnings of $0.17 per share when it actually produced earnings of $0.08, delivering a surprise of -52.94%.Over the last four quarters, the company has surpassed co ...
Prothena (PRTA) Reports Q3 Loss, Lags Revenue Estimates
ZACKS· 2025-11-07 07:46
Prothena (PRTA) came out with a quarterly loss of $0.67 per share versus the Zacks Consensus Estimate of a loss of $0.6. This compares to a loss of $1.1 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -11.67%. A quarter ago, it was expected that this drug developer would post a loss of $1.11 per share when it actually produced a loss of $1.86, delivering a surprise of -67.57%.Over the last four quarters, the company has not be ...
Protagonist Therapeutics (PTGX) Reports Q3 Loss, Lags Revenue Estimates
ZACKS· 2025-11-07 07:46
Protagonist Therapeutics (PTGX) came out with a quarterly loss of $0.62 per share versus the Zacks Consensus Estimate of a loss of $0.59. This compares to a loss of $0.54 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -5.08%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of $0.53 per share when it actually produced a loss of $0.55, delivering a surprise of -3.77%.Over the last four quart ...
Mettler-Toledo (MTD) Beats Q3 Earnings and Revenue Estimates
ZACKS· 2025-11-07 07:46
Mettler-Toledo (MTD) came out with quarterly earnings of $11.15 per share, beating the Zacks Consensus Estimate of $10.62 per share. This compares to earnings of $10.21 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +4.99%. A quarter ago, it was expected that this maker of precision instruments would post earnings of $9.58 per share when it actually produced earnings of $10.09, delivering a surprise of +5.32%.Over the last fo ...
Ongoing government shutdown and AI fears are putting the market under pressure, Jim Cramer says
CNBC· 2025-11-07 07:45
CNBC's Jim Cramer unpacked Thursday's market decline, telling investors that Wall Street is worried about the lengthy government shutdown and that artificial intelligence buildout is getting out of control."What matters is we need the darn government to go back to work, and we need the data center blob to be cordoned off from the rest of the economy, and we need some of the hottest stocks to continue to cool off further," he said. "Until then, we are indeed at the mercy of the headlines and, lately, the dar ...
Shamis & Gentile, P.A. Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of agilon health, inc.
Globenewswire· 2025-11-07 07:44
MIAMI, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The law firm of Shamis & Gentile, P.A. is investigating whether certain directors and officers of agilon health, inc. (NYSE: AGL) breached their fiduciary duties owed to the company. If you are an agilon health shareholder, you are encouraged to contact the law firm for more information: agilon health Shareholder Investigation Impacted shareholders may also contact attorney David Abel at securities@shamisgentile.com or (305) 479-2299. There is no cost or obligation t ...